DJ Eli Lilly & Co. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Eli Lilly & Co. $(LLY)$ shed 1.44% to $807.58 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.94% to 6,033.11 and the Dow Jones Industrial Average rising 0.75% to 42,515.09.
The stock's fall snapped a six-day winning streak.
Eli Lilly & Co. closed 16.96% below its 52-week high of $972.53, which the company achieved on August 22nd.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 1.20% to $155.22, Pfizer Inc. $(PFE)$ fell 0.57% to $24.40, and AbbVie Inc. $(ABBV)$ fell 0.12% to $190.86.
Trading volume (2.8 M) remained 1.5 million below its 50-day average volume of 4.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 16, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 16, 2025 16:31 ET (20:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.